The human gut contains approximately 38 trillion microorganisms — bacteria, fungi, viruses and archaea — collectively weighing around 1.5 kilograms and encoding roughly 150 times more genes than the human genome. This inner ecosystem, known as the gut microbiome, has emerged over the last two decades as one of the most consequential discoveries in modern medicine. Far from being passive passengers, these microorganisms are active participants in virtually every aspect of human physiology.
The microbiome digests food that the human body cannot — producing short-chain fatty acids, vitamins (including B12, K2 and folate), neurotransmitter precursors and immune-regulating compounds. It trains and calibrates the immune system, maintaining the tolerance that prevents the body from attacking its own tissues. It communicates with the brain via the gut-brain axis — producing 90% of the body's serotonin and approximately 50% of its dopamine in the gut, where these compounds regulate gut motility and signal to the brain via the vagus nerve.
The microbiome is exquisitely sensitive to diet, lifestyle, stress, sleep, antibiotic use and environmental exposure. A disrupted microbiome — dysbiosis — has been implicated in an expanding list of conditions: inflammatory bowel disease, metabolic syndrome, obesity, type 2 diabetes, cardiovascular disease, autoimmune conditions, depression, anxiety, autism spectrum disorder and neurodegenerative diseases. The gut is no longer considered a peripheral organ. It is a central regulator of health, disease and consciousness.